CMXHF — CSL LTD
—
OTC ·
Unknown ·
Unknown ·
CIK 1274152 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
2026-08-17
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | 33,646,000,000 | 1,513,000,000 | 17,339,000,000 |
| Dec 2024 | 8,213,000,000 | 4,279,000,000 | 1,977,000,000 | 2,007,000,000 | 38,447,000,000 | 1,524,000,000 | 17,901,000,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$17,331,000,000
Inventory
$6,139,000,000
Receivables
$3,606,000,000
ST Investments
—
EBIT TTM
$2,753,000,000
Pretax Income TTM
$2,540,000,000
Interest Exp TTM
$213,000,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$15,797,000,192
EBITDA
$5,078,000,128
Free Cash Flow
$1,892,875,008
Enterprise Value
$71,321,968,640
Total Cash
$1,512,999,936
Total Debt
$10,896,000,000
Shares Out
479,884,274
Trailing EPS
$-5.35
Book Value
$30.90
ROE
-15.8%
ROA
7.3%
Div Yield
2.31%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 15,698,000,000 | 3,101,000,000 | -2,579,000,000 | 33,646,000,000 | 17,339,000,000 | 14,797,000,000 | — |
| Jun 2025 | 15,430,000,000 | 2,959,000,000 | 3,002,000,000 | 39,404,000,000 | 17,997,000,000 | 19,335,000,000 | — |
| Jun 2024 | 14,690,000,000 | 2,764,000,000 | 2,642,000,000 | 38,022,000,000 | 18,621,000,000 | 17,363,000,000 | — |
| Jun 2023 | 13,174,000,000 | 2,102,000,000 | 2,194,000,000 | 36,234,000,000 | 18,408,000,000 | 15,786,000,000 | — |
| Jun 2022 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BRRN | Bryn Inc. | $945.00B | $2100.00 | — |
| SPY | SPDR S&P 500 ETF TRUST | $707.93B | $771.35 | — |
| TMO | THERMO FISHER SCIENTIFIC INC. | $249.58B | $675.00 | — |
| KLAC | KLA CORP | $245.53B | $187.92 | — |
| IBM | INTERNATIONAL BUSINESS MACHINES CORP | $212.46B | $225.51 | — |
News headlines (Yahoo Finance, 1h cache)
CSL Reports Positive Top-Line Phase 3b Results Supporting Planned Expanded Pediatric Filing for ANDEMBRY® (garadacimab-gxii) in Children with Hereditary Angioedema (HAE)
2026-07-27 13:00 · Yahoo
CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union
2026-06-26 13:00 · Yahoo
Should Value Investors Buy CSL Limited (CSLLY) Stock?
2026-05-04 13:40 · Yahoo
CSLLY vs. ACAD: Which Stock Is the Better Value Option?
2026-04-30 15:40 · Yahoo
CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?
2026-04-14 15:40 · Yahoo
Why Is CSL (ASX:CSL) Launching Its New Flu Vaccine First In The UK?
2026-09-23 00:18 · Yahoo
Expanded ANDEMBRY Reimbursement In Canada Could Be A Game Changer For CSL (ASX:CSL)
2026-09-22 17:12 · Yahoo
Public Access to ANDEMBRY® (garadacimab) Expands Across Canada for the Prevention of Hereditary Angioedema (HAE) Attacks
2026-09-22 12:00 · Yahoo
Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults
2026-09-10 22:40 · Yahoo
CSL Ltd's Dividend Analysis
2026-09-10 11:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.